Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8946)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2018 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vespasiani-Gentilucci U, Gallo P, Dell’Unto C, Volpentesta M, Antonelli-Incalzi R, Picardi A. Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables. World J Gastroenterol 2018; 24(43): 4835-4845 [PMID: 30487694 DOI: 10.3748/wjg.v24.i43.4835] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i43/4835.htm |
| Number | Citing Articles |
| 1 |
Cristiana Bianco, Federica Tavaglione, Stefano Romeo, Luca Valenti. Genetic risk scores and personalization of care in fatty liver disease. Current Opinion in Pharmacology 2021; 61: 6 doi: 10.1016/j.coph.2021.08.014
|
| 2 |
Antonio De Vincentis, Federica Tavaglione, Stefano Romeo, Umberto Vespasiani-Gentilucci. Reply. Clinical Gastroenterology and Hepatology 2022; 20(11): 2660 doi: 10.1016/j.cgh.2022.01.010
|
| 3 |
Fatemeh Ghadiri, Abbas Ali Husseini, Oğuzhan Öztaş. A machine-learning approach for nonalcoholic steatohepatitis susceptibility estimation. Indian Journal of Gastroenterology 2022; 41(5): 475 doi: 10.1007/s12664-022-01263-2
|
| 4 |
Chiara Zusi, Alessandro Mantovani, Francesca Olivieri, Anita Morandi, Massimiliano Corradi, Emanuele Miraglia Del Giudice, Marco Dauriz, Luca Valenti, Christopher D. Byrne, Giovanni Targher, Claudio Maffeis. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents. Digestive and Liver Disease 2019; 51(11): 1586 doi: 10.1016/j.dld.2019.05.029
|
| 5 |
Antonio De Vincentis, Federica Tavaglione, Oveis Jamialahmadi, Antonio Picardi, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci. A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores. Clinical Gastroenterology and Hepatology 2022; 20(3): 658 doi: 10.1016/j.cgh.2021.05.056
|
| 6 |
Antonio De Vincentis, Federica Tavaglione, Rocco Spagnuolo, Roberta Pujia, Dario Tuccinardi, Gianluca Mascianà, Antonio Picardi, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci. Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank. International Journal of Obesity 2022; 46(3): 486 doi: 10.1038/s41366-021-01015-w
|
| 7 |
V. Wendy Setiawan, Hugo R. Rosen. Stratification of Residual Risk of HCC Following HCV Clearance With Direct‐Acting Antivirals in Patients With Advanced Fibrosis and Cirrhosis. Hepatology 2020; 72(6): 1897 doi: 10.1002/hep.31639
|
| 8 |
Karla Sawada Toda-Oti, José Tadeu Stefano, Ana Mercedes Cavaleiro, Flair José Carrilho, Maria Lúcia Correa-Gianella, Cláudia Pinto Marques de Souza de Oliveira. Association of UCP3 Polymorphisms with Nonalcoholic Steatohepatitis and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease Brazilian Patients. Metabolic Syndrome and Related Disorders 2022; 20(2): 114 doi: 10.1089/met.2020.0104
|
| 9 |
Jia-Min Yang, Yan Sun, Min Wang, Xin-Lei Zhang, Shu-Jing Zhang, Yu-Shan Gao, Lin Chen, Meng-Yao Wu, Lu Zhou, Yu-Mei Zhou, Yue Wang, Feng-Jie Zheng, Yu-Hang Li. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. World Journal of Gastroenterology 2019; 25(34): 5105-5119 doi: 10.3748/wjg.v25.i34.5105
|
| 10 |
Yuping Zeng, He He, Zhenmei An, Jin Chai. Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/1254014
|
| 11 |
Alessia Di Costanzo, Lucia Pacifico, Laura D’Erasmo, Luca Polito, Michele Di Martino, Francesco Massimo Perla, Ludovica Iezzi, Claudio Chiesa, Marcello Arca. Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children. International Journal of Molecular Sciences 2019; 20(18): 4444 doi: 10.3390/ijms20184444
|
| 12 |
Kana Daijo, Takashi Nakahara, Yuki Inagaki, Maiko Nanba, Yuno Nishida, Shinsuke Uchikawa, Kenichiro Kodama, Kazuki Oya, Kei Morio, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Masami Yamauchi, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Akira Hiramatsu, C Nelson Hayes, Michio Imamura, Hiroshi Aikata, Hidenori Ochi, Kazuaki Chayama. Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy cases. Journal of Gastroenterology and Hepatology 2020; 35(8): 1412 doi: 10.1111/jgh.14968
|
| 13 |
Ângelo Z Mattos, Jose D Debes, Renu Dhanasekaran, Jihane N Benhammou, Marco Arrese, André Luiz V Patrício, Amanda C Zilio, Angelo A Mattos. Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge. World Journal of Hepatology 2021; 13(9): 1107-1121 doi: 10.4254/wjh.v13.i9.1107
|
| 14 |
Pierre Nahon, Manon Allaire, Jean-Charles Nault, Valérie Paradis. Characterizing the Mechanism Behind the Progression of NAFLD to Hepatocellular Carcinoma. Hepatic Oncology 2020; 7(4) doi: 10.2217/hep-2020-0017
|
| 15 |
Shan Tang, Jing Zhang, Ting-Ting Mei, Hai-Qing Guo, Xin-Huan Wei, Wen-Yan Zhang, Ya-Li Liu, Shan Liang, Zuo-Peng Fan, Li-Xia Ma, Wei Lin, Yi-Rong Liu, Li-Xia Qiu, Hai-Bin Yu. Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6173-4
|
| 16 |
Chengxiao Yu, Yuchen Tang, Maojie Liu, Xin Xu, Xinyuan Ge, Hongxia Ma, Guangfu Jin, Hongbing Shen, Ci Song, Zhibin Hu. The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma. Journal of Gastroenterology 2024; 59(11): 1011 doi: 10.1007/s00535-024-02144-5
|
| 17 |
György M. Buzás. Helicobacter pylori and non-alcoholic fatty liver disease. Minerva Gastroenterologica e Dietologica 2020; 66(3) doi: 10.23736/S1121-421X.20.02671-9
|
| 18 |
Jun Wang, David V. Conti, David Bogumil, Xin Sheng, Mazen Noureddin, Lynne R. Wilkens, Loic Le Marchand, Hugo R. Rosen, Christopher A. Haiman, Veronica Wendy Setiawan. Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort. Hepatology Communications 2021; 5(10): 1689 doi: 10.1002/hep4.1751
|
| 19 |
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, Giovanni Targher, Christopher D. Byrne, Dan-Qin Sun, Ming-Hua Zheng. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nature Reviews Nephrology 2022; 18(4): 259 doi: 10.1038/s41581-021-00519-y
|
| 20 |
Monica A. Tincopa. Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis. Endocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.177
|
| 21 |
Antonio De Vincentis, Rosellina Margherita Mancina, Jussi Pihlajamäki, Ville Männistö, Salvatore Petta, Paola Dongiovanni, Anna Ludovica Fracanzani, Luca Valenti, Federica Tavaglione, Stefano Romeo, Umberto Vespasiani‐Gentilucci. Genetic variants in the MTHFR are not associated with fatty liver disease. Liver International 2020; 40(8): 1934 doi: 10.1111/liv.14543
|
| 22 |
Wen Wen, Hua Fan, Shenghui Zhang, Siqi Hu, Chen Chen, Jiake Tang, Yao You, Chunyi Wang, Jie Li, Lin Luo, Yongran Cheng, Mengyun Zhou, Xuezhi Zhao, Tao Tan, Fangfang Xu, Xinyan Fu, Juan Chen, Peng Dong, Xingwei Zhang, Mingwei Wang, Yan Feng. Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease. The American Journal of the Medical Sciences 2024; 368(6): 557 doi: 10.1016/j.amjms.2024.06.022
|
| 23 |
Lasin Ozbek, Sama Mahmoud Abdel-Rahman, Selen Unlu, Mustafa Guldan, Sidar Copur, Alexandru Burlacu, Adrian Covic, Mehmet Kanbay. Exploring Adiposity and Chronic Kidney Disease: Clinical Implications, Management Strategies, Prognostic Considerations. Medicina 2024; 60(10): 1668 doi: 10.3390/medicina60101668
|
| 24 |
Aynur Unalp‐Arida, Constance E. Ruhl. Patatin‐Like Phospholipase Domain‐Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population. Hepatology 2020; 71(3): 820 doi: 10.1002/hep.31032
|
| 25 |
Li-jie Chen, Jing Guo, Song-xia Zhang, Ying Xu, Qing Zhao, Wei Zhang, Jian Xiao, Yao Chen. Sirtuin3 rs28365927 functional variant confers to the high risk of non-alcoholic fatty liver disease in Chinese Han population. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01520-x
|
| 26 |
Shubham Jain, Ravi Thanage, Falguni Panchal, Pravin M. Rathi, Renuka Munshi, Suhas S. Udgirkar, Qais Q. Contractor, Sanjay J. Chandnani, Nair P. Sujit, Partha Debnath, Anupam Singh. Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link?. Journal of Clinical and Experimental Hepatology 2021; 11(4): 466 doi: 10.1016/j.jceh.2020.10.003
|
| 27 |
Helene Gellert‐Kristensen, Tom G. Richardson, George Davey Smith, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Stefan Stender. Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population. Hepatology 2020; 72(3): 845 doi: 10.1002/hep.31238
|
| 28 |
Francesca Terracciani, Andrea Falcomatà, Paolo Gallo, Antonio Picardi, Umberto Vespasiani-Gentilucci. Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers. Journal of Physiology and Biochemistry 2023; 79(4): 851 doi: 10.1007/s13105-022-00934-0
|
| 29 |
Nataša Milošević, Maja Milanović, Jan Sudji, Dragana Bosić Živanović, Stefan Stojanoski, Bojan Vuković, Nataša Milić, Milica Medić Stojanoska. Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans?. Environmental Science and Pollution Research 2020; 27(1): 772 doi: 10.1007/s11356-019-06831-2
|
| 30 |
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021; doi: 10.7759/cureus.20776
|
| 31 |
Jaehyun Bae, Byung-Wan Lee. Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease. Biomedicines 2023; 11(7): 1928 doi: 10.3390/biomedicines11071928
|
| 32 |
Abbas Ali Husseini. Genotypic variation in CYP2E1, GCKR, and PNPLA3 among nonalcoholic steatohepatitis patients of Turkish origin. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09787-w
|
| 33 |
Stefano Ministrini, Fabrizio Montecucco, Amirhossein Sahebkar, Federico Carbone. Macrophages in the pathophysiology of NAFLD: The role of sex differences. European Journal of Clinical Investigation 2020; 50(6) doi: 10.1111/eci.13236
|